Skip to main content

SEM & SENS ANNOUNCEMNTS

SEM & SENS ANNOUNCEMENTS

2026

19 January

Finalisation Announcement in Respect of the Numeral Share Consolidation
20 January

Information on Share Consolidation and Results of Special Meeting of Shareholders
21 January

Short Form Sens Announcement Summary of the Unaudited Financial Statements for the Nine Months Ended 30 November 2025
21 January

Unaudited Financial Results for the Nine Months Ended 30 November 2025
29 January

Share Consolidation – Fractional Entitlements
24 February

Issue of Shares for Cash – Extension of Closing date
22 April

Update Announcement and Renewal of Cautionary
15 June

Numeral SENS SEM Classification Change SENSFINAL
15 June

Numeral SEM Announcement for Further Extension Publishing 28 Feb 2026 AFS SEM SENS FINAL
29 June

Appointment of Non-Executive Director
09 July

Numeral Update on Longevity and Isopharm
15 July

Consolidated and Separate Annual Financial Statements for the year ended 28 February 2026
20 July

Updated Audited Financial Results For The Year Ended 28 February 2026 And Restatement Of Results For The Year Ended 28 February 2025
20 July

Updated Short Form Sens Announcement – Summary Of The Audited Financial Statements For The Year Ended 28 February 2026
20 July

Extension Of Deadline To Release Q1 Financial Results For The Period Ending 31 May 2026
20 July

Consolidated and Separate Annu February al Financial Statements for the year ended
22 July

Updated Audited Financial Results for the year ended 28 February 2026 and Restatement of Results for the year ended 28 February 2025
22 July

Short form SENS announcement – Availability of the annual financial statements for the year ended 28 February 2026
28 July

No change statement, posting of annual report and notice of annual meeting

2025

17 January

Unaudited Financial Results for the nine months ended 30 November 2024
17 January

Short Form Sense Announcement – Summary of the Unaudited Financial Statements for the Nine months Ended 30 November 2024
26 February

Issue of new global business licence
18 March

Appointment of Director
2 June

Extension of deadline to release financial results
16 July

Short Form Sens Announcement – Summary Of The Unaudited Abridged Financial Statements For The Three Months Ended 31 May 2025 And Change In Director
16 July

Unaudited Financial Results For The Three Months Ended 31 May 2025 (“Q1”) And Change In
Director
23 July

Annual Report_28 February2025_Signed
23 July

Notice of Annual Meeting
23 July

Numeral

Change Statement Posting of Annual Report Notice of Annual Meeting 230725 SENS FINAL
15 August

Results of Annual Meeting of Shareholders
17 October

Short Form Announcement – Summary Of The Unaudited Abridged Financial Statements For The Six Months Ended 31 August 2025
17 October

Unaudited Financial Results For The Six Months Ended 31 August 2025
13 November

Communique – Proposed Consolidation Of Shares And Issue Of Shares For Cash
19 December

Consolidation of Share Issues of Shares for Cash. JSE Formal Admission
19 December

Communique – Proposed Consolidation Of Shares And Issue Of Shares For Cash

2024

2023

28 February

Financial Statements for the Year Ended 28 February 2023
28 February

Further Extension of Deadline to release Financial results
22 March

Appointment of Financial Director
10 May

Communique – Issue of Shares
10 July

Correction Announcement – Auditors
7 August

Audited Financial Results for the Year Ended 28 February 2023
7 August

Short Form Sense Announcement – Summary of the Audited Financial Statement for the year Ended 28 February 2023
7 August

Audited Financial Results for the Year Ended 28 February 2023
7 August

Short Form Sense Announcement – Summary of the Audited Financial Statements for the Year Ended 28 February 2023
19 October

Changes to the Board, Proposed Board Restructure, Update on Appointment of New Management Company, Company Secretary, Transfer Secretary and Extension of Time to Report
27 October

Changes to the Board and Board Restructure
6 November

Change of Name of the Company
6 November

Change of Name: Amendment to Listing
6 November

Circular Regarding the Change of Name of the Company
15 November

Appointment of Director
20 November

Short form Sens Announcement – Summary of the Unaudited Abridge Financial Statements for the Three Months Ended 31 May 2023
20 November

Unaudited Financial Results for the Three Months Ended 31 May 2023
22 November

Results of General Meeting (GM) of Shareholders – Name Change
22 November

Adjournment of Meetings of Shareholders
24 November

Update Change of Name of the Company
24 November

Appointment of new Management Company, Company Secretary and Registry Services
29 November

Unaudited Financial Results for the Six Months Ended 31 August 2023
29 November

Short Form Sens Announcement – Summary of the Unaudited Abridge Financial Statements for the Six Months Ended 31 August 2023
20 December

Registration of Change of Name of the Company and Salient Date

2022